<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR108">
 <label>108.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sarparanta</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Bimbo</surname>
    <given-names>LM</given-names>
   </name>
   <name>
    <surname>Rytkönen</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Mäkilä</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Laaksonen</surname>
    <given-names>TJ</given-names>
   </name>
   <name>
    <surname>Laaksonen</surname>
    <given-names>P</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution</article-title>
  <source>Mol Pharm.</source>
  <year>2012</year>
  <volume>9</volume>
  <issue>3</issue>
  <fpage>654</fpage>
  <lpage>663</lpage>
  <pub-id pub-id-type="doi">10.1021/mp200611d</pub-id>
  <?supplied-pmid 22277076?>
  <pub-id pub-id-type="pmid">22277076</pub-id>
 </element-citation>
</ref>
